ClinicalTrials.Veeva

Menu

Identification of Heart Failure Patients by Seismocardiography (SCG-HF)

A

Acarix

Status

Completed

Conditions

Heart Failure

Treatments

Device: Seismocardiography

Study type

Observational

Funder types

Industry

Identifiers

NCT03656354
AC013AOU

Details and patient eligibility

About

The aim of the current study is to develop and validate an algorithm based on seismocardiography recordings to detect heart failure. Echocardiography will be used as the golden standard for defining patients with heart failure.

Full description

Seismocardiography is inspired from methods for the analysis of seismic activity and can be used to describe the heart's movements using a specially developed sensor placed on the patient's chest. The project aims to describe the motion of the heart using automated computer analysis of the seismocardiography signal for development of a simple method for the analysis of myocardial performance.

Enrollment

219 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, aged 18 years or older
  • Clinically suspected heart failure, and referred to an outpatient clinic
  • Be able and willing to comply with the clinical investigational plan
  • Have signed the informed consent form

Exclusion criteria

  • Known HF
  • Known atrial fibrillation
  • Acute coronary syndrome
  • Implanted donor heart, mechanical heart, mechanical heart pump, pacemaker or Cardioverter Defibrillator (ICD)
  • Implanted electronic equipment in the area above and around the heart
  • Significant operation scars, abnormal body shape, fragile or compromised skin in the seismocardiographic recording area (fourth left Inter Costal space and xiphoid process)
  • Pregnancy

Extension study:

Inclusion criteria

  1. Male or female, aged 18 years or older
  2. Newly diagnosed HFREF
  3. Be able and willing to comply with the clinical investigational plan
  4. Have signed the informed consent form

Exclusion criteria

  1. Known atrial fibrillation
  2. Acute coronary syndrome
  3. Implanted donor heart, mechanical heart, mechanical heart pump, pacemaker or Cardioverter Defibrillator (ICD)
  4. Implanted electronic equipment in the area above and around the heart
  5. Significant operation scars, abnormal body shape, fragile or compromised skin in the seismocardiographic recording area (fourth left Inter Costal space and xiphoid process)
  6. Pregnancy

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems